This is a topic I am very passionate about, and something I am learning every day. I hope you will enjoy the read, and you will find it useful. Happy to hear your views about the topic. The mindful scientist network.febs.org/posts/the-mind… #FEBSnet

Promontory Point in Winter. 50 picture pano. Can't wait to get some freezing temperatures and pancakes again #Chicago

Just out: UChicagoCancerCenter researchers published exciting results demonstrating the role of HIF-1α in inducing pancreatic ductal carcinoma. Simon Schwörer Memorial Sloan Kettering Cancer Center University of Chicago Hematology/Oncology UChicago Committee on Cancer Biology Cancer Research ow.ly/rxzv50NhcnG

Pancreatic tumors exhibit myeloid-driven amino acid stress and upregulate arginine biosynthesis doi.org/10.7554/eLife.…

Cancer: How nearby nutrients shape tumour growth. elifesciences.org/articles/89825…

Today's Nobel is a reminder to focus on the work and not the journal. The key publications cited by the committee were published in Immunity, Molecular Therapy, and Nucleic Acids Research. Respectable journals, but not the Big 3. The discoveries are what's important, not a name.

Want a simple rule? Does the lab judge its success by where it publishes? Does it consider a Science, Cell or Nature paper to be the highest accomplishment? If so, it's not serious about doing science right. You should join a lab that's fighting the system, not playing in it.

When I meet other scientists, we more often discuss how to cope with failure rather than to achieve success. So I wrote this piece. I'd love to hear your views. "Uno su mille ce la fa". Rethinking a scientist’s success network.febs.org/posts/uno-su-m… #FEBSnet

Check out Alex and I’s latest review! I’m proud of how this came together and excited for the future of the field of lipid metabolism in the tumor microenvironment!

I’m geeked to share that I’ll be starting my lab at the CU Anschutz Medical Campus CU Pharmacology on July 1st! The Oliphant (Oli) Lab will leverage multi-omics approaches and organoid models to advance our understanding of breast cancer evolution, metabolic reprogramming, and drug resistance.

Hi #metabolism #pancreaticcancer #lipidtime twitter! Excited to share Patrick Jonker work on how the microenvironment limits the metabolic capacity of pancreatic cancers (PDAC), which sensitizes these tumors to dietary interventions. 1/17

My two NIH cancer research grants were terminated today. One involving breast cancer prevention is an “outstanding investigator award” and had received a perfect score by reviewers. How does ending lifesaving cancer research make Americans healthier? Harvard Medical School @aacr

More than scientists, because if labs close this will lead to losses in jobs that support R&D nationally. Our #SCIMaP analysis estimates that FY26 NIH cuts alone will lead to $46B in economic losses and 202K lost jobs in communities throughout the US. scienceimpacts.org/fy26

It shouldn't get lost that just today, Senate Republicans have voted to close nursing homes, close rural hospitals, and cut food stamp benefits for children and veterans.

Republicans are celebrating the passage of the largest Medicaid cut in U.S. history to pay for the largest tax break for billionaires in American history. 51,000 Americans will die each year so that the top 1% can get a $1 trillion tax break. This bill is a death sentence.

RFK: “microplastics are bad” (cites recent study from OSU) EPA: on same day, cancels that research grant on microplastics to OSU #MAHA npr.org/sections/shots…

Wow this dye comes from a flower?? It must be incredibly safe. I've never heard of a toxic flower. Naturalistic fallacy is real folks

What’s on the menu?: metabolic constraints in the pancreatic tumor microenvironment Colin Sheehan & @Muirlab The University of Chicago review nutrient limitations in PDAC, adaptations to metabolic stress, and next steps for revealing critical dependencies and targets: jci.org/articles/view/…

Human mitochondria connect with each other at a distance through thin membrane protrusions called "nanotunnels" As if they are "reaching out for help". Mitochondria in people with mitochondrial diseases show more nanotunnels in healthy mitochondria do. Below is one of the most

2 weeks ago had a chance to attend the Gordon conference on synthetic lethality approaches in oncology w Patrick Jonker. Absolutely amazing group of people to learn from. Highly recommend to anyone interested in the topic when it returns again in 2 years.